FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
The historical rank and industry rank for Ypsomed Holding AG's FCF Yield % or its related term are showing as below:
LTS:0QLQ'
s FCF Yield % Range Over the Past 10 Years
Min: -4.95 Med: -1.5 Max: 2.17
Current: -0.35
During the past 13 years, the highest FCF Yield % of Ypsomed Holding AG was 2.17%. The lowest was -4.95%. And the median was -1.50%.
LTS:0QLQ's FCF Yield % is ranked better than 50.41% of 857
companies
in the Medical Devices & Instruments industry
Industry Median: -0.4
vs LTS:0QLQ: -0.35
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Ypsomed Holding AG FCF Yield % Related Terms
Ypsomed Holding AG FCF Yield % Historical Data
* Premium members only.
The historical data trend for Ypsomed Holding AG's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LTS:0QLQ vs ISRG, BDX, MDLN: FCF Yield % Comparison
For the Medical Instruments & Supplies subindustry, Ypsomed Holding AG's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ypsomed Holding AG FCF Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Ypsomed Holding AG's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Ypsomed Holding AG's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ypsomed Holding AG (LTS:0QLQ) has a FCF Yield % of -0.35 as of Jul. 04, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Ypsomed Holding AG and its competitors. According to the industry distribution chart, Ypsomed Holding AG ranks #425 out of 857 companies in the Medical Devices & Instruments industry, placing it in the top 49.6%.
Is Ypsomed Holding AG's FCF Yield % too high?
Ypsomed Holding AG's current FCF Yield % is -0.35. Based on the distribution chart, Ypsomed Holding AG ranks #425 out of 857 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Ypsomed Holding AG has a GF Score™ of 82/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Ypsomed Holding AG's FCF Yield % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Ypsomed Holding AG ranks #425 out of 857 companies for FCF Yield %. This puts Ypsomed Holding AG in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Medical Devices & Instruments company?
A good FCF Yield % depends on the Medical Devices & Instruments industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Ypsomed Holding AG and its competitors. Ypsomed Holding AG's current FCF Yield % is -0.35. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ypsomed Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Ypsomed Holding AG (LTS:0QLQ) is currently considered Fairly Valued. The stock's GF Value™ is CHF397.12, compared to a current price of CHF359.40 — trading 9.5% below its estimated fair value. The current FCF Yield % is -0.35. Ypsomed Holding AG's overall GF Score™ is 82/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Ypsomed Holding AG (LTS:0QLQ), the current FCF Yield % is -0.35 as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ypsomed Holding AG (LTS:0QLQ) Overvalued in 2026?
Based on GuruFocus' analysis, Ypsomed Holding AG stock appears to be undervalued.
The current stock price of CHF359.40 is trading 9.5% below its estimated GF Value™ of CHF397.12.
GuruFocus considers Ypsomed Holding AG to be Fairly Valued.
Key valuation signals for LTS:0QLQ:
FCF Yield %: -0.35
GF Value™: CHF397.12 vs. price of CHF359.40 (9.5% below fair value)
No single metric tells the full story. See the LTS:0QLQ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ypsomed Holding AG is a Swiss company that develops and manufactures injection and infusion systems that allow patients to self-administer medication. Specifically, the company focuses on ensuring the ease of diabetes and insulin injection. The company offers various products such as pen needles with a click-on function. The company operates under two reportable segments: Ypsomed Delivery Systems and Ypsomed Diabetes Care.
82GF Score
Get the complete analysis for LTS:0QLQ
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0QLQ has been successfully added to your 
